ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,409,000 | +30.0% | 3,338,718 | -16.5% | 0.75% | +37.1% |
Q1 2020 | $4,160,000 | -45.0% | 4,000,000 | 0.0% | 0.55% | -64.7% |
Q4 2019 | $7,560,000 | +366.7% | 4,000,000 | +166.7% | 1.56% | +543.8% |
Q3 2019 | $1,620,000 | -50.7% | 1,500,000 | 0.0% | 0.24% | -53.6% |
Q2 2019 | $3,285,000 | -63.4% | 1,500,000 | 0.0% | 0.52% | -64.0% |
Q1 2019 | $8,985,000 | -18.9% | 1,500,000 | 0.0% | 1.45% | -23.0% |
Q4 2018 | $11,085,000 | – | 1,500,000 | – | 1.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |